DUBLIN, May 6, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/c3n2v6/otc) has announced the addition of the "OTC Pharmaceuticals Market in Latin America 2014-2018" report to their offering.
The analysts forecast the OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals Market in Latin America has also been witnessing the same key increased outsourcing of drug development activities. However, the stringent regulations are expected to pose a challenge to the growth of this market.
The report, the OTC Pharmaceuticals Market in Latin America Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the OTC Pharmaceuticals Market in Latin America market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Bayer HealthCare AG., EMS S.A., Hypermarcas S.A., and Novartis AG. Other vendors mentioned in the report are Boehringer Ingelheim GmbH., Genomma Lab Internacional SAB., GlaxoSmithKline plc., Johnson & Johnson, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
06. Market Landscape
07. Market Segmentation by Products
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
16. Key Vendor Analysis
17. Other Reports in this Series
- Bayer HealthCare AG.
- EMS S.A.
- Hypermarcas S.A.
- Novartis AG.
For more information visit http://www.researchandmarkets.com/research/c3n2v6/otc
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets